MERCK & CO. INC. (MRK) Stock Fundamental Analysis

NYSE:MRK • US58933Y1055

121.41 USD
+2.17 (+1.82%)
At close: Feb 13, 2026
121.4 USD
-0.01 (-0.01%)
After Hours: 2/13/2026, 8:26:57 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, MRK scores 6 out of 10 in our fundamental rating. MRK was compared to 191 industry peers in the Pharmaceuticals industry. While MRK has a great profitability rating, there are some minor concerns on its financial health. MRK has a correct valuation and a medium growth rate. MRK also has an excellent dividend rating. These ratings would make MRK suitable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year MRK was profitable.
  • MRK had a positive operating cash flow in the past year.
  • MRK had positive earnings in each of the past 5 years.
  • Of the past 5 years MRK 4 years had a positive operating cash flow.
MRK Yearly Net Income VS EBIT VS OCF VS FCFMRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

1.2 Ratios

  • MRK has a Return On Assets of 14.69%. This is amongst the best in the industry. MRK outperforms 94.76% of its industry peers.
  • MRK has a better Return On Equity (36.71%) than 95.81% of its industry peers.
  • MRK has a Return On Invested Capital of 20.32%. This is amongst the best in the industry. MRK outperforms 96.86% of its industry peers.
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROIC 20.32%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRK Yearly ROA, ROE, ROICMRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • The Profit Margin of MRK (29.63%) is better than 94.24% of its industry peers.
  • In the last couple of years the Profit Margin of MRK has grown nicely.
  • MRK's Operating Margin of 36.99% is amongst the best of the industry. MRK outperforms 96.34% of its industry peers.
  • MRK's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 77.69%, MRK belongs to the top of the industry, outperforming 83.25% of the companies in the same industry.
  • MRK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 36.99%
PM (TTM) 29.63%
GM 77.69%
OM growth 3Y6.33%
OM growth 5Y9.38%
PM growth 3Y4.66%
PM growth 5Y10.53%
GM growth 3Y4.72%
GM growth 5Y2.48%
MRK Yearly Profit, Operating, Gross MarginsMRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MRK is creating value.
  • MRK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MRK Yearly Shares OutstandingMRK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
MRK Yearly Total Debt VS Total AssetsMRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • MRK has an Altman-Z score of 4.38. This indicates that MRK is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of MRK (4.38) is better than 73.82% of its industry peers.
  • MRK has a debt to FCF ratio of 3.17. This is a good value and a sign of high solvency as MRK would need 3.17 years to pay back of all of its debts.
  • MRK has a better Debt to FCF ratio (3.17) than 89.01% of its industry peers.
  • MRK has a Debt/Equity ratio of 0.77. This is a neutral value indicating MRK is somewhat dependend on debt financing.
  • MRK has a worse Debt to Equity ratio (0.77) than 69.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Altman-Z 4.38
ROIC/WACC2.24
WACC9.08%
MRK Yearly LT Debt VS Equity VS FCFMRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.66 indicates that MRK should not have too much problems paying its short term obligations.
  • The Current ratio of MRK (1.66) is worse than 67.54% of its industry peers.
  • MRK has a Quick Ratio of 1.44. This is a normal value and indicates that MRK is financially healthy and should not expect problems in meeting its short term obligations.
  • MRK has a Quick ratio of 1.44. This is in the lower half of the industry: MRK underperforms 64.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.44
MRK Yearly Current Assets VS Current LiabilitesMRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • MRK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.16%, which is quite impressive.
  • MRK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.13% yearly.
  • The Revenue has been growing slightly by 1.31% in the past year.
  • MRK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.38% yearly.
EPS 1Y (TTM)20.16%
EPS 3Y7.06%
EPS 5Y9.13%
EPS Q2Q%21.51%
Revenue 1Y (TTM)1.31%
Revenue growth 3Y3.12%
Revenue growth 5Y9.38%
Sales Q2Q%4.97%

3.2 Future

  • Based on estimates for the next years, MRK will show a small growth in Earnings Per Share. The EPS will grow by 1.63% on average per year.
  • The Revenue is expected to grow by 2.49% on average over the next years.
EPS Next Y-41.06%
EPS Next 2Y4.38%
EPS Next 3Y5.65%
EPS Next 5Y1.63%
Revenue Next Year4.34%
Revenue Next 2Y4.82%
Revenue Next 3Y4.55%
Revenue Next 5Y2.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MRK Yearly Revenue VS EstimatesMRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
MRK Yearly EPS VS EstimatesMRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.23, the valuation of MRK can be described as correct.
  • MRK's Price/Earnings ratio is rather cheap when compared to the industry. MRK is cheaper than 89.01% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.68. MRK is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 22.44, MRK is valued on the expensive side.
  • MRK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MRK is cheaper than 75.39% of the companies in the same industry.
  • MRK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.23
Fwd PE 22.44
MRK Price Earnings VS Forward Price EarningsMRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MRK is valued cheaper than 86.91% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, MRK is valued cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.09
EV/EBITDA 11.45
MRK Per share dataMRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • MRK has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.45
EPS Next 2Y4.38%
EPS Next 3Y5.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • MRK has a Yearly Dividend Yield of 2.85%.
  • MRK's Dividend Yield is rather good when compared to the industry average which is at 1.18. MRK pays more dividend than 93.72% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, MRK pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.85%

5.2 History

  • On average, the dividend of MRK grows each year by 6.90%, which is quite nice.
  • MRK has paid a dividend for at least 10 years, which is a reliable track record.
  • MRK has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.9%
Div Incr Years14
Div Non Decr Years34
MRK Yearly Dividends per shareMRK Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 42.60% of the earnings are spent on dividend by MRK. This is a bit on the high side, but may be sustainable.
  • The dividend of MRK is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP42.6%
EPS Next 2Y4.38%
EPS Next 3Y5.65%
MRK Yearly Income VS Free CF VS DividendMRK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
MRK Dividend Payout.MRK Dividend Payout, showing the Payout Ratio.MRK Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

MERCK & CO. INC.

NYSE:MRK (2/13/2026, 8:26:57 PM)

After market: 121.4 -0.01 (-0.01%)

121.41

+2.17 (+1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-03
Earnings (Next)04-30
Inst Owners80.32%
Inst Owner Change-89.08%
Ins Owners0.05%
Ins Owner Change-0.69%
Market Cap301.34B
Revenue(TTM)65.01B
Net Income(TTM)19.03B
Analysts77.06
Price Target118.61 (-2.31%)
Short Float %1.36%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield 2.85%
Yearly Dividend3.1
Dividend Growth(5Y)6.9%
DP42.6%
Div Incr Years14
Div Non Decr Years34
Ex-Date03-16
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.37%
Min EPS beat(2)7.69%
Max EPS beat(2)13.06%
EPS beat(4)4
Avg EPS beat(4)7.28%
Min EPS beat(4)2.93%
Max EPS beat(4)13.06%
EPS beat(8)8
Avg EPS beat(8)21.72%
EPS beat(12)12
Avg EPS beat(12)16.45%
EPS beat(16)16
Avg EPS beat(16)15.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)0.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)0.41%
Revenue beat(12)9
Avg Revenue beat(12)1.14%
Revenue beat(16)13
Avg Revenue beat(16)1.98%
PT rev (1m)7.46%
PT rev (3m)17.4%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-1.81%
EPS NY rev (1m)-41.43%
EPS NY rev (3m)-43.18%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE 13.23
Fwd PE 22.44
P/S 4.69
P/FCF 23.09
P/OCF 17.66
P/B 5.81
P/tB 20.16
EV/EBITDA 11.45
EPS(TTM)9.18
EY7.56%
EPS(NY)5.41
Fwd EY4.46%
FCF(TTM)5.26
FCFY4.33%
OCF(TTM)6.88
OCFY5.66%
SpS25.88
BVpS20.89
TBVpS6.02
PEG (NY)N/A
PEG (5Y)1.45
Graham Number65.69
Profitability
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROCE 23.54%
ROIC 20.32%
ROICexc 24.8%
ROICexgc 44.78%
OM 36.99%
PM (TTM) 29.63%
GM 77.69%
FCFM 20.31%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y6.33%
OM growth 5Y9.38%
PM growth 3Y4.66%
PM growth 5Y10.53%
GM growth 3Y4.72%
GM growth 5Y2.48%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Debt/EBITDA 1.41
Cap/Depr 87.9%
Cap/Sales 6.25%
Interest Coverage 17.91
Cash Conversion 60.24%
Profit Quality 68.56%
Current Ratio 1.66
Quick Ratio 1.44
Altman-Z 4.38
F-Score6
WACC9.08%
ROIC/WACC2.24
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.16%
EPS 3Y7.06%
EPS 5Y9.13%
EPS Q2Q%21.51%
EPS Next Y-41.06%
EPS Next 2Y4.38%
EPS Next 3Y5.65%
EPS Next 5Y1.63%
Revenue 1Y (TTM)1.31%
Revenue growth 3Y3.12%
Revenue growth 5Y9.38%
Sales Q2Q%4.97%
Revenue Next Year4.34%
Revenue Next 2Y4.82%
Revenue Next 3Y4.55%
Revenue Next 5Y2.49%
EBIT growth 1Y-0.15%
EBIT growth 3Y9.65%
EBIT growth 5Y19.64%
EBIT Next Year-15.41%
EBIT Next 3Y12.42%
EBIT Next 5Y2.91%
FCF growth 1Y-12.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.56%
OCF growth 3YN/A
OCF growth 5YN/A

MERCK & CO. INC. / MRK FAQ

What is the fundamental rating for MRK stock?

ChartMill assigns a fundamental rating of 6 / 10 to MRK.


Can you provide the valuation status for MERCK & CO. INC.?

ChartMill assigns a valuation rating of 6 / 10 to MERCK & CO. INC. (MRK). This can be considered as Fairly Valued.


Can you provide the profitability details for MERCK & CO. INC.?

MERCK & CO. INC. (MRK) has a profitability rating of 8 / 10.


What is the financial health of MERCK & CO. INC. (MRK) stock?

The financial health rating of MERCK & CO. INC. (MRK) is 5 / 10.


How sustainable is the dividend of MERCK & CO. INC. (MRK) stock?

The dividend rating of MERCK & CO. INC. (MRK) is 7 / 10 and the dividend payout ratio is 42.6%.